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SUMMARY
Very little is known about the spatiotemporal genera-
tion of lipid droplets (LDs) from the endoplasmic re-
ticulum (ER) and the factors that mediate ER-LD con-
tacts for LD growth. Using super-resolution grazing
incidence structured illumination microscopy (GI-
SIM) live-cell imaging, we reveal that upon LD induc-
tion, the ER-localized protein DFCP1 redistributes to
nascent puncta on the ER, whose formation depends
on triglyceride synthesis. These structures move
along the ER and fuse to form expanding LDs. Fusion
and expansion of DFCP1-labeled nascent structures
is controlled by BSCL2. BSCL2 depletion causes
accumulation of nascent DFCP1 structures. DFCP1
overexpression increases LD size and enhances
ER-LD contacts, while DFCP1 knockdown has the
opposite effect. DFCP1 acts as a Rab18 effector for
LD localization and interacts with the Rab18-ZW10
complex to mediate ER-LD contact formation. Our
study reveals that fusion of DFCP1-labeled nascent
structures contributes to initial LD growth and that
the DFCP1-Rab18 complex is involved in tethering
the ER-LD contact for LD expansion.
INTRODUCTION
The lipid droplet (LD) consists of neutral lipids (e.g., triglycerides
and sterol esters) that are enwrapped by a phospholipid mono-
layer (Yang et al., 2012; Joshi et al., 2017; Walther et al., 2017).
The LD surface is decorated with proteins that regulate lipid stor-
age, metabolism, and movement of droplets (Kory et al., 2016).
LDs originate from the endoplasmic reticulum (ER), and their for-
mation involves discrete steps (Kassan et al., 2013; Wang et al.,
2016). Neutral lipids synthesized in the ER bilayer membrane
accumulate to form lens-like structures (Choudhary et al.,
2015; Walther et al., 2017; Qi et al., 2017). The growing droplet
progressively distends the ER membrane and eventually buds
off into the cytoplasm to form a nascent LD (Choudhary et al.,
2015; Walther et al., 2017; Qi et al., 2017). The egress of neutral
lipids from the bilayer membrane and LD budding is specified by
the ER phospholipid composition and surface tension (Ben
M’barek et al., 2017; Choudhary et al., 2018). The ER transmem-
brane protein FIT2 (fat-storage-inducing transmembrane) facili-
tates the emergence of LDs from the ER, probably by regulating
diacylglycerol (DAG) levels at the sites of LD biogenesis
(Choudhary et al., 2015). Very little is known about the dynamics
of the initial stage of LD formation. For example, whether a
nascent LD is generated from individual neutral lipid-containing
LD precursors or involves fusion of LD precursors remains
unknown.
Nascent LDs, which may be connected to the ER or separated
completely from it, reengagewith the ER for expansion. LDs form
contacts with the ER, in which two membranes are closely
apposed (typically within 30 nm) and/or are physically connected
with the ER by narrowmembrane stalks. At the contact sites and
membrane extensions, neutral lipids synthesized in the ER are
transported to LDs for growth (Walther et al., 2017; Joshi et al.,
2017). ER-resident biosynthetic enzymes for neutral lipids,
such as GPAT4 and DGAT2, also transfer from the ER to the
LD surface via membrane connections for local lipid synthesis
(Wilfling et al., 2013). Lipolysis of LDs also induces ER-LD con-
tacts for back transport of phospholipids and droplet proteins
to the ER (Kory et al., 2016). LD growth can also result from fusion
of LDs, which rarely occurs under normal conditions. Fusion of
LDs is facilitated by phosphatidylcholine (PC) deficiency, phos-
phatidic acid (PA) accumulation, or expression of the LD-local-
ized protein Fsp27 (Fei et al., 2011; Krahmer et al., 2011; Gong
et al., 2011).
Membrane contact sites (MCSs) are established by protein-
protein and/or protein-phosphoinositide interactions between
the two opposingmembranes (Phillips and Voeltz, 2016). Several
factors have been identified that are involved in the formation
and/or maintenance of ER-LD contact. The lipid synthesis en-
zymes FATP1 (acetyl coenzyme A [acyl-CoA] synthetase) and
DGAT2 (diacylglycerol acyltransferase), which are located on
the ER and the LD, respectively, have been shown to form a
complex to tether the ER to LDs, thus coupling the synthesis
and deposition of triglycerides (TGs) into LDs (Xu et al., 2012).
The GTP-bound form of Rab18 interacts with the NRZ tethering
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factors (NAG-RINT1-ZW10) and their associated ER-localized
SNAREs (Use1, Syntaxin18, and BNIP1) to promote the forma-
tion of ER-LD contacts for LD growth in preadipocytes (Xu
et al., 2018). The formation of membrane bridges between LDs
and the ER is promoted by the Arf1-coatomer protein (COP) I
machinery, which removes phospholipids from the LD surface
and in turn increases LD surface tension (Thiam et al., 2013; Wil-
fling et al., 2014). The stability of ER-LD contact is modulated by
the ER-localized transmembrane protein EPG-3 (also known as
VMP1), which activates the calcium transporter SERCA (Zhao
et al., 2017). The ER-resident transmembrane protein BSCL2,
encoded by human Berardinelli-Seip congenital lipodystrophy
2, forms discrete foci at ER-LD contacts and controls the growth
of nascent LDs to largemature LDs (Wang et al., 2016; Salo et al.,
2016). BSCL2 depletion causes accumulation of a large number
of nascent LDs (not labeled by lipid dyes), clusters of small LDs,
and a few supersized LDs (Wang et al., 2016; Salo et al., 2016).
The supersized LDs result from aberrant targeting of lipid
synthesis enzymes and/or LD coalescence due to changes in
phospholipid composition (Wang et al., 2016; Salo et al., 2016;
Wolinski et al., 2015). In BSCL2-depleted cells, ER-LD contacts
are heterogeneous and morphologically irregular (Salo et al.,
2016). How BSCL2 participates in the formation, function, and/
or stabilization of ER-LD contacts remains largely unknown.
The ER also plays a pivotal role in the formation of the double-
membrane autophagosome in higher eukaryotes (Zhao and
Zhang, 2018). Upon autophagy induction, the Atg14L-Vps34
phosphatidylinositol 3-phosphate (PI(3)P) kinase complex is tar-
geted to the ER to synthesize PI(3)P (Itakura and Mizushima,
2010). The PI(3)P-enriched ER subdomains, known as omega-
somes, act as platforms for autophagosome formation (Axe
et al., 2008). The omegasome extensively contacts and also
forms membrane extensions with the isolation membrane (IM;
autophagosomal precursor) during its expansion into an auto-
phagosome (Zhao and Zhang, 2018). The FYVE-domain-con-
taining ER-localized protein DFCP1 (also known as ZFYVE1)
migrates to omegasomes upon autophagy induction, a process
that depends on both the ER localization domain and the PI(3)P-
binding FYVE domain (Axe et al., 2008). DFCP1 does notmove to
IMs, and it migrates back to the ER when the IM closes into
the autophagosome (Axe et al., 2008). Although DFCP1 labels
omegasomes, its knockdown (KD) causes no evident autophagy
defects (Axe et al., 2008). DFCP1 is also identified as a compo-
nent of the LD proteome (Bersuker et al., 2018), but its function in
LD metabolism remains unknown.
Using a newly developed super-resolution live-cell imaging
technique, we demonstrated that upon LD induction, DFCP1
forms small puncta on the ER in a manner that depends on TG
synthesis. These DFCP1-labeled nascent structures move along
the ER and fuse to form an expanding LD, which further grows
into a large LD. BSCL2 is required for fusion and growth of
DFCP1-labeled nascent structures. DFCP1 KD reduces, while
DFCP1 overexpression enhances, ER-LD contacts. DFCP1
acts as a Rab18 effector and interacts with the Rab18-ZW10
complex to mediate ER-LD contact. Our study reveals that initial
LD growth involves fusion of nascent DFCP1-labeled structures,
and LD expansion is modulated by the DFCP1-mediated ER-LD
contact.
RESULTS
DFCP1 Relocates from the ER to LDs upon LD Induction
Under normal conditions, GFP-DFCP1 colocalized with the ER
markers RFP-Sec61b and DsRed-KDEL (Figures 1A and S1A)
(Axe et al., 2008). After 6-h oleic acid (OA) treatment, DFCP1
tightly enclosed LDs stained by LipidTOX, and the fluorescence
intensity of GFP-DFCP1 on the ER was concomitantly
decreased in COS7 and HeLa cells (Figures 1B, S1B, and
S1C). GFP-DFCP1 fluorescence was enriched at LD-LD contact
sites compared to other regions of LDs (Figures 1B and S1B–
S1E). DFCP1-RFP also colocalized with the LD markers ACSL3
and GPAT4 after 6-h OA treatment (Figures 1C and S1F).
Biochemical fractionation assays revealed that endogenous
DFCP1 protein was present in purified LDs (Figure S1G). Levels
of DFCP1mRNA and proteins did not change after OA treatment
(Figures S1H and S1I). We reconstructed the LD surface in three
dimensions (3D) from deconvoluted structured illumination mi-
croscopy (SIM) images of LDs labeled by DFCP1 and found
that DFCP1 was on the LD surface and tightly enwrapped the
lipids (Figure 1D; Video S1).
The localization of DFCP1 was further determined by immuno-
electron microscopy (EM) analysis. Gold particles recognizing
GFP-DFCP1 specifically localized on the phospholipid mono-
layer surrounding LDs but were barely detected on the ER mem-
brane (Figure 1E). More gold particles accumulated at LD-LD
contact sites (Figure 1F). We also visualized the localization of
DFCP1 using the chimeric APEX2-DFCP1 protein. APEX2 is an
engineered peroxidase that catalyzes the formation of a highly
electron-dense substance in the presence of diaminobenzidine
(DAB) and OsO4, thus facilitating the EM analysis of protein
localization (Lam et al., 2015). Dark APEX2-DFCP1 signals
were detected at the surface of LDs and the signal was stronger
at LD-LD contact sites (Figures S1J and S1K). Taken together,
these results show that DFCP1 redistributes from the ER to
LDs after OA treatment.
We performed fluorescence recovery after photobleaching
(FRAP) assays to examine the mobility of DFCP1 on LDs. After
6-h OA treatment, the GFP-DFCP1 fluorescence signal was
bleached on a portion of the LD. We found that the GFP signal
recovered within 2 s (Figures 1G and 1H). Recovery of the
DFCP1 signal was also observed after bleaching of an entire
LD (either a single LD or an LD within a cluster; Figures 1G and
1H). Thus, DFCP1 on the LD is mobile and exchanges with the
ER and/or cytosol pool of DFCP1.
LD Localization of DFCP1 Depends on the ER Targeting
Domain and the FYVE Domain
DFCP1 contains an ER targeting domain and also a phosphoino-
sitide-binding FYVE domain (Figure S2A). We treated the mem-
brane fraction of cellular extracts with high pH (pH 11.5) or
high-salt (0.5 M NaCl) buffers and found that endogenous
DFCP1 was present in the supernatant but absent in the pellet
(membrane fraction), suggesting that DFCP1 is not an integral
transmembrane ER protein (Figure S2B). The mutation GFP-
DFCP1(W543A), which disrupts the ER localization of DFCP1
(Axe et al., 2008), prevented DFCP1 from anchoring onto LDs
(Figure 1I). ER(DFCP1)-GFP, containing only the ER targeting
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Figure 1. The ER-Localized Protein DFCP1 Moves to LDs upon LD Induction in a Manner Dependent on Its ER-Targeting Domain and FYVE
Domain
(A) GI-SIM images reveal that under normal conditions, GFP-DFCP1 colocalizes with the ER marker RFP-Sec61b. Scale bar, 2 mm (insert, 400 nm). The
experiments were performed in COS7 cells unless otherwise stated.
(B) SIM analysis shows that GFP-DFCP1 encloses LipidTOX-stained LDs. The fluorescence intensity is stronger at LD-LD contact sites.
(C) DFCP1-RFP colocalizes with ACSL3-GFP on LDs after 6-h OA treatment.
(B and C) Scale bars, 5 mm (inserts, 2 mm).
(D) 3D-SIM image shows that DFCP1 tightly enwraps an LD. Weak GFP-DFCP1 signals on LDs failed to be reconstituted in 3D-SIM images. Scale bar, 200 nm.
(E and F) Immuno-EM analysis reveals that after 6-h OA treatment, gold particles (white arrowheads), indicating GFP-DFCP1, localize on the LD surface (E) and
are enriched at the contact sites (F). Scale bars, 200 nm (inserts, 100 nm).
(G) After 6-h OA treatment in HeLa cells, the fluorescence signal of GFP-DFCP1 recovered after photobleaching. Arrowheads indicate the site where the GFP
signal was photobleached. Scale bars, 1 mm.
(H) The graph shows the time-dependent recovery of GFP-DFCP1 fluorescence on LDs after photobleaching in HeLa cells treated with OA for 6 h (n = 6 LDs for
each independent experiment). Mt indicates the proportion of bleached protein that is replaced by unbleached protein during the recovery monitoring period; t1/2
is the half-time of recovery, i.e., the time that the fluorescence reaches half of its maximal recovery intensity. Mean ± SEM is shown.
(I) GFP-DFCP1(W543A) fails to anchor on LDs.
(J) The ER targeting domain of DFCP1 (aa 416–543) labels LDs.
(K) The signal from ER+FYVE(DFCP1)-GFP on LDs is as strong as full-length DFCP1.
(L) GFP-DFCP1(C650S and C770S) encloses LDs.
In (I)–(L), schematic structures of the mutant DFCP1 proteins are shown on top. The mutation site in (I and L) is indicated by an asterisk (*). Scale bars, 5 mm
(inserts, 2 mm) (I–L).
See also Figures S1 and S2.
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domain of DFCP1, labeled LDs after OA treatment, but the fluo-
rescence signal on the LD was weaker than that of DFCP1 (Fig-
ure 1J). Chimeric proteins containing the ER-targeting domain of
DFCP1 and the FYVE domain derived from DFCP1 or FENS,
ER+FYVE(DFCP1) and ER(DFCP1)+FYVE(FENS), exhibited a
strong GFP signal on the LD, like full-length DFCP1 (Figures 1K
and S2C). Compared to DFCP1 and ER+FYVE(DFCP1), the
half-time for recovery of the ER(DFCP1)-GFP fluorescence
signal after photobleaching on LDs and the ER was shorter (Fig-
ures S2D–S2G). Thus, the FYVE domain contributes to the reten-
tion of DFCP1 on LDs.
Upon autophagy induction, DFCP1 moves to omegasomes in
a manner that depends on the binding of PI(3)P to the FYVE
domain and is abolished by wortmannin treatment (Axe et al.,
2008). After OA treatment for 6 h, DFCP1 still colocalized with
LC3 puncta upon starvation (Figure S2H). The LD localization
of DFCP1, however, persisted after wortmannin treatment (Fig-
ure S2I). Mutations in the FYVE domain residues that are critical
for PI(3)P binding, C650S and C770S (Axe et al., 2008), did not
prevent DFCP1 from localizing to LDs (Figure 1L). Thus, PI(3)P
is not required for the redistribution of DFCP1 from the ER to
LDs. FYVE(FENS)-TM(CytoB5)-GFP, in which the bilayer-span-
ning ER domain from CytoB5 is linked to the FYVE domain of
FENS, labels the omegasome (Axe et al., 2008). However, it
failed to be recruited to LDs (Figure S2J). These results indicate
that the ER-targeting domain and FYVE domain mediate the LD
localization of DFCP1.
DFCP1 Labels Nascent LD Structures on the ER that
Move and Fuse to Form an Expanding LD at the Early
Stages of LD Biogenesis
We used grazing incidence structured illumination microscopy
(GI-SIM) to examine the spatiotemporal recruitment of GFP-
DFCP1 to LDs upon OA treatment. Compared to spinning-disk
confocal microscopy or commercial SIM systems, GI-SIM pro-
vides a higher spatiotemporal resolution of 95 nm and 40 frames
per second. Moreover, its axial illumination depth reaches
1 mm, enabling us to examine the dynamics of subcellular or-
ganelles (Nixon-Abell et al., 2016). Formation of LDs at different
stages can be monitored by different assays. LipidTOX stains
LDs with a moderate amount of neutral lipid accumulation.
HPos (containing the ER-anchoring hydrophobic domain of
ALDI and the LD-targeting motif of caveolin-1) translocates
from the ER to LDs before lipid accumulation can be stained
by neutral lipid dyes (e.g., LipidTOX and BODIPY) (Kassan
et al., 2013) and thus serves as a marker to detect the early
stages of LD formation.
Time-lapse analysis using GI-SIM was performed to examine
the temporal relationship of GFP-DFCP1 with mCherry-HPos.
Before OA addition, GFP-DFCP1 colocalized with the ERmarker
RFP-Sec61b or mCherry-HPos on the ER (Figures 1A and 2A).
After OA treatment for 5 min, GFP-DFCP1 started to form a
few new puncta, which were negative for mCherry-HPos, on
the ER (Figure S3A). The number of DFCP1 puncta continued
to increase up until 15 min (Figures 2B and 2D). A fraction of
DFCP1 puncta became positive for mCherry-HPos (Figures 2B
and 2D). After OA treatment for 20 min, only a few small
DFCP1 puncta were present, but the GFP-DFCP1+ mCherry-
HPos+ puncta gradually enlarged and became ring-like struc-
tures that continued to grow (Figures 2C, 2D, S3B, and S3C).
During LD formation, the GFP-DFCP1 signal intensity on the
LD increased (Figure S3D).
We further analyzed the dynamics of DFCP1 puncta. 64.1% of
DFCP1 puncta dissipated into the ER (Figures 2E and 2H; Video
S2), indicating that punctum formation is reversible. 33.1%of the
DFCP1 puncta rapidly moved along the ER and fused with each
Figure 2. Dynamics of DFCP1-Labeled LD Structures during the Early Stages of LD Biogenesis
(A) GI-SIM images show that before OA treatment, GFP-DFCP1 colocalizes with mCherry-HPos on the ER.
(B) After 15-min OA treatment, GFP-DFCP1 colocalizes with mCherry-HPos on the ER. Some GFP-DFCP1 puncta colocalizes with mCherry-HPos (yellow
arrowheads in all three panels indicate the same punctum) at three-way junction sites of the ER.
(C) After OA treatment for 20 min, almost all GFP-DFCP1 puncta colocalize with mCherry-HPos (yellow arrowheads).
(A–C) Scale bars, 2 mm (inserts, 400 nm).
(D) Quantification of the number of different types of GFP-DFCP1 structures at different time points after OA treatment. n = 13 areas of 10 mm2 from 5 cells were
examined for each time point. Data are shown as mean ± SEM.
(E) GI-SIM images at a series of time-points after OA addition show that DFCP1+HPos puncta (arrowheads in the top panel) decrease in intensity and gradually
disappear into the ER. Scale bar, 400 nm.
(F) GI-SIM images at a series of time points after the addition of OA show that DFCP1+HPos puncta (white arrowheads in the top panel) move alone the ER and
fuse with a nearby DFCP1+HPos+ punctum (yellow arrowhead) at the ER three-way junction site. Scale bar, 800 nm.
(G) The sequential order of punctum labeling byGFP-DFCP1,mCherry-HPos, and LipidTOX. 00 0 refers to the time point for analysis, not the onset of OA treatment.
63.3% of GFP-DFCP1+ mCherry-HPos+ puncta are localized at ER three-way junction (yellow arrow) (n = 79 puncta in 4 cells). Arrowheads indicate the
emergence of each marker at the same punctum on the ER. Scale bar, 800 nm.
(H) Dynamics of nascent DFCP1 puncta during early stage of LD biogenesis (n = 8 areas of 10 mm2 from 4 cells were examined within 25-min OA treatment). Data
are shown as mean ± SEM.
(I–K) EM images of cells expressing APEX2 (I), APEX2-DFCP1 (J), and APEX2-LiveDrop (K). DAB does not stain the ER membrane in APEX2-expressing control
cells (I). The DAB-stained papillary structure on the ER is indicated by arrow. Arrowheads indicate spherical structures adjacent to the ER. Scale bars, 200 nm
(inserts, 100 nm).
(L) The number of DAB-stained structures in cells expressing APEX2-LiveDrop and APEX2-DFCP1 (n = 14 and 17 areas of 2 mm2 from EM images, respectively,
were examined after OA treatment for 15 min). Data are shown as mean ± SEM.
(M) Treatment with the DGAT1 inhibitor D1i suppresses the formation of nascent DFCP1 puncta after OA treatment.
(N) The number of nascent DFCP1 puncta decreases in FIT2 KD cells after OA treatment.
(M and N) Scale bars, 2 mm.
See also Figure S3.
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other and/or a DFCP1 punctum that was already positive for
mCherry-HPos or LipidTOX, resulting in growth of the puncta
(Figures 2F, 2H, and S3E; Video S2). 63.3% of GFP-DFCP1+
mCherry-HPos+ puncta were formed at three-way junctions of
ER tubules (Figure 2G). Some DFCP1 puncta also detached
from, and then migrated back to, the ER (Figure S3F). 2.8% of
DFCP1 puncta grew into LDs that were stained by LipidTOX (Fig-
ure 2H). We also determined the dynamics of GFP-DFCP1,
mCherry-HPos, and LipidTOX upon OA treatment. After OA
treatment, GFP-DFCP1 puncta first emerged on the ER and
then became mCherry-HPos positive. The puncta were then
gradually stained by LipidTOX (Figure 2G). The DFCP1 puncta
negative for LipidTOX staining are named hereafter as nascent
DFCP1 puncta.
The resolution of GI-SIM could not differentiate between
structures on the ER or adjacent (<100 nm) to the ER. We per-
formed EM analysis to further characterize DFCP1 structures
at early stages of LD biogenesis. After OA treatment for
15 min, in APEX2-DFCP1-expressing cells, DAB stained small
papillary structures on the ER and also spherical structures
(<100 nm) adjacent to the ER (Figures 2I, 2J, and 2L). Formation
of puncta positive for LiveDrop, a widely used nascent LD
marker (Wang et al., 2016), occurred later than DFCP1 (Fig-
ure S3G). APEX2-LiveDrop labeled spherical structures
(<100 nm) close to the ER but only a few papillary structures
(Figures 2K and 2L).
To further determine whether DFCP1 puncta represent early
LD structures, we treated cells with the TG synthesis inhibitor
D1i, which inhibits DGAT1 activity. We found that formation of
nascent DFCP1 puncta was almost abolished (Figure 2M). FIT2
regulates emergence of LDs from the ER. FIT2 KD causes a dra-
matic reduction in the number and size of LDs (Choudhary et al.,
2015). Knocking down FIT2 dramatically reduced the formation
of nascent DFCP1 puncta (Figures 2N and S3H), suggesting
that DFCP1-labeled structures are LD precursors. Taken
together, these results indicate that DFCP1 is an earlier LD
marker than mCherry-HPos and labels nascent LD structures,
which fuse to form expanding LDs.
BSCL2 Controls Dissipation and Fusion of DFCP1-
Labeled Nascent LDs
BSCL2 acts at the ER-LD contact site to regulate LD biogenesis
(Wang et al., 2016; Salo et al., 2016). After 6-h OA treatment,
BSCL2-GFP or endogenous BSCL2 formed distinct puncta
that associate with LDs in control cells (Wang et al., 2016; Salo
et al., 2016) (Figures S4A and S4C). In cells expressing
mCherry-DFCP1, BSCL2-GFP, or endogenous BSCL2 closely
encircled DFCP1-labeled LDs (Figures S4B and S4D). We
knocked down BSCL2 by RNAi in COS7 and HeLa cells to
examine whether BSCL2 regulates the dynamics of DFCP1
puncta during LD formation (Figures S4E–S4G). After 6-h OA
treatment, the number of GFP-DFCP1 puncta wasmuch greater,
while the localization of DFCP1 on LipidTOX-stained LDs was
weaker, in BSCL2 KD cells than in negative control (NC) cells
(Figures 3A, 3B, S4H, and S4I). BSCL2 depletion also sup-
pressed the LD localization of ER(DFCP1)-GFP (Figures S4J
and S4K). These results indicate that BSCL2 regulates DFCP1
targeting to mature LDs.
We next performed time-lapse analysis using GI-SIM to
determine the spatiotemporal formation of DFCP1 puncta in
BSCL2 KD cells. Before addition of OA, ER localization of
DFCP1 was weaker in BSCL2 KD cells than in NC cells (Figures
3C and S4L), suggesting that BSCL2 regulates the ER associa-
tion of DFCP1. After OA treatment, nascent DFCP1 puncta
emerged from the ER in BSCL2 KD cells (Figures 3D–3F and
3H). In control cells, GFP-DFCP1+mCherry-HPos puncta
matured into GFP-DFCP1+mCherry-HPos+ puncta and then
grew into ring structures (Figures 2G and S3C), while in
BSCL2 KD cells, fewer GFP-DFCP1+mCherry-HPos+ puncta
grew into ring structures (Figures 3D–3F and 3H). GFP-
DFCP1+mCherry-HPos puncta were able to move to the ER
three-way junctions in BSCL2 KD cells and become GFP-
DFCP1+mCherry-HPos+ puncta (Figure 3G; Video S3). How-
ever, they were not stably anchored at the three-way junction.
The GFP-DFCP1+mCherry-HPos puncta migrated away (Fig-
ure 3G; Video S3). In BSCL2 KD cells, GFP-DFCP1+mCherry-
HPos+ puncta sometimes formed clusters at the ER three-
way junction, but the clusters were irregularly shaped and failed
to grow in size (Figure S4M; Video S3). The dissipation of GFP-
DFCP1+mCherry-HPos puncta into the ER was also inhibited
in BSCL2 KD cells (Figure 3I; Video S3). Therefore, a large num-
ber of nascent GFP-DFCP1 puncta persisted even after 20-min
OA treatment inBSCL2KD cells (Figures 3F and 3H).BSCL2 KD
cells also contained a few GFP-DFCP1+mCherry-HPos+ ring
structures, with which nascent DFCP1 puncta could fuse (Fig-
ure S4N). The growth of these LD structures was faster than
in control cells (Figure S4O). However, the increase in DFCP1
fluorescence intensity on LDs was less in BSCL2 KD cells (Fig-
ures S4O and S4P). Depletion of BSCL2 resulted in accumula-
tion of nascent LDs, which were not stained by LipidTOX (Wang
et al., 2016). BSCL2 KD cells contain both small and supersized
LipidTOX-positive LDs (Wang et al., 2016; Salo et al., 2016) (Fig-
ures S4Q and S4R). EM analysis showed that APEX2-DFCP1
strongly labeled nascent LDs (<100 nm), but not small and
supersized LDs (300 nm and 1 mm, respectively) in BSCL2
KD cells (Figure 3J). Therefore, BSCL2 is required for the matu-
ration of DFCP1-labeled nascent LDs into LipidTOX-positive
mature LDs.
DFCP1 Regulates the Size of LDs
We next investigated the role of DFCP1 in LD biogenesis.DFCP1
was knocked down by small interfering RNA (siRNA) in COS7
and HeLa cells (Figures S5A and S5B). After 6-h OA treatment,
the average size of LDs was 0.78 mm in control COS7 cells and
1.45 mm in control HeLa cells, which was reduced to 0.65 mm
and 1.18 mm in DFCP1 KD cells, respectively (Figures 4A–4C
and S5C–S5E). The number of LDs increased in DFCP1 KD cells
(Figures 4D and S5F). Compared to control mouse embryonic fi-
broblasts (MEFs), LDs were also smaller and more abundant in
DFCP1 KO MEFs (Figures S5A and S5G–S5J). In contrast to
DFCP1 KD, overexpression of GFP-DFCP1 increased the size
of LDs (Figures 4E–4G). LDs also formed clusters in DFCP1-
overexpressing cells (Figure 4F). Overexpression of ER(DFCP1)
and ER+FYVE(DFCP1) also increased LD size (Figures 4G,
S5K, and S5L). These results indicate that DFCP1 regulates
the size and distribution of LDs.
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DFCP1 Modulates the Formation of ER Contacts
with LDs
After OA treatment for 6 h, the ER marker GFP-Sec61b was
separable from LDs in control cells (Figure S5M) while they
closely enveloped the LDs in DFCP1-overexpressing cells (Fig-
ure S5N). This suggests that the ER is closely associated with
LDs. The mobility of LDs is affected by their association with
the ER (Salo et al., 2016). We measured LD mobility after 1-h
OA treatment and found that it was increased from 0.060 mm/s
in control cells to 0.106 mm/s in DFCP1 KD cells and reduced
to 0.051 mm/s in DFCP1-overexpressing cells (Figures S5O–
S5R). We also purified LDs to assess the association of ER
with LDs. The ER-localized protein Sec61b dramatically accu-
mulated in LDs purified from DFCP1-overexpressing cells
compared to control cells (Figure 4H).
EM analysis was performed to directly visualize the contact
between the ER and LDs. Compared to control cells, the per-
centage of LDs in contact with the ER, as well as their average
perimeter, was decreased in DFCP1 KD cells (Figures 4I–4L),
while ER-LD contact was dramatically elevated in cells
Figure 3. BSCL2 Regulates the Fusion of Nascent DFCP1 Puncta and the LD Localization of DFCP1
(A and B) After 6-h OA treatment, compared with NC cells (A), the localization of DFCP1 on LipidTOX-positive LDs is greatly suppressed andmany punctate GFP-
DFCP1 structures are present in BSCL2 KD COS7 cells (B). Scale bars, 5 mm (inserts, 2 mm).
(C) GI-SIM images show that the ER localization of DFCP1 is weaker before OA addition in BSCL2 KD cells. A few DFCP1+HPos puncta (green arrows in the
merge panel) are present on the ER.
(D–F) The formation of DFCP1 puncta at different time points after OA treatment in BSCL2 KD cells. The number of DFCP1+HPos puncta (green arrowheads)
remains high from 5 min to 20 min (D–F). A few GFP-DFCP1 ring structures colocalize with mCherry-HPos in small or large LDs (yellow arrows in E and F). Scale
bars, 2 mm (C–F).
(G) GI-SIM images at selected time points after OA addition showing the movement of nascent DFCP1 puncta in BSCL2 KD cells. One DFCP1+HPos punctum
(green arrow) moves along the ER to the three-way junction site (white arrowhead), where it stays from 60200 0–60500 0 before moving away on the ER. Another
DFCP1+HPos punctum (OA 70400 0–90100 0, green arrowhead) moves along the ER and touches the first DFCP1 punctum (green arrowhead) at the ER three-way
junction site. The two nascent DFCP1 puncta then separate onto different ER strands and do not fuse or grow in size. The ER three-way junction is a highly
dynamic structure. Scale bar, 800 nm.
(H) Quantification of the number of DFCP1 structures inBSCL2KD cells (n = 13 areas of 10 mm2 from 5 cells were examined for each time point). Data are shown as
mean ± SEM.
(I) The percentage of DFCP1+HPos puncta that dissipate into the ER within 25 min in wild-type and BSCL2 KD cells (wild-type, n = 210 nascent DFCP1 puncta
from 4 cells; BSCL2 KD, n = 142 nascent DFCP1 puncta from 4 cells). Data are shown as mean ± SEM. ***p < 0.001.
(J) Cells expressing APEX2-DFCP1 shows that strong DAB-stained signals locate on nascent LDs (<100 nm), but not on small or supersized LDs (300 nm and
1 mm, respectively), in BSCL2 KD cells. Arrowheads indicate DAB-stained structures. Scale bar, 200 nm (insert, 100 nm).
See also Figure S4.
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Figure 4. DFCP1 Regulates the Size of LDs and the Formation of ER-LD Contacts
(A and B) After 6-h OA treatment, DFCP1 KD cells (B) contain more and smaller LDs than control (NC) cells (A). Scale bars, 5 mm (inserts, 2 mm).
(C) The size of LDs in NC and DFCP1 KD COS7 cells (NC, n = 124 LDs from 7 cells; DFCP1 KD, n = 200 LDs from 10 cells). Data are shown as mean ± SD. ***p <
0.001.
(D) The number of LDs per cell (NC, n = 7 cells; DFCP1 KD, n = 10 cells) is quantified and shown as mean ± SEM. *p < 0.05.
(E–G) Overexpression of DFCP1 (F) increases the LD size in COS7 cells, compared with control cells (E). The structure near the nucleus that is strongly positive for
GFP-DFCP1 but negative for LipidTOX is the Golgi apparatus. Quantification of the LD size in cells expressing GFP, GFP-DFCP1, ER+FYVE(DFCP1)-GFP, and
ER(DFCP1)-GFP (n = 90, 102, 116, and 91 LDs, respectively) is shown in (G) as mean ± SD. Related to Figures S5G and S5H. ***p < 0.001. Scale bars, 5 mm
(inserts, 2 mm).
(legend continued on next page)
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overexpressing ER(DFCP1) or DFCP1 (Figures 4M–4Q). ER-LD
contact was also decreased in DFCP1 KD and increased in
DFCP1-overexpressing HeLa cells (Figures S5S–S5W). Thus,
DFCP1 promotes the formation of ER-LD contacts.
We next examined the formation of the FATP1-DGAT2 com-
plex, which has been shown to tether the ER to LD contacts
for LD expansion (Xu et al., 2012). Levels of FATP1 co-immuno-
precipitated by DGAT2 were higher in DFCP1-overexpressing
cells and lower in DFCP1 KD cells (Figures 4R and 4S), support-
ing a role of DFCP1 in mediating ER-LD contact.
Rab18 Is Required for LD Targeting of DFCP1 and for the
Role of DFCP1 in Mediating ER-LD Contact
Previous studies showed that upon LD induction, Rab18 local-
izes to LDs and induces close apposition of LDs with the ER
(Ozeki et al., 2005). The LD localization of Rab18 depends on
its activation (Ozeki et al., 2005). A GTPase-defective mutant
(Q67L) of Rab18, but not a GDP-bound mutant (S22N), showed
LD localization in COS7 cells (Figures S6A and S6B). DFCP1-
RFP colocalized with GFP-Rab18(Q67L) on LDs after 6-h OA
treatment (Figure S6C). Rab18 binds to the NAG-RINT-ZW10
(NRZ) tethering complex to modulate ER-LD contact in preadi-
pocytes (Xu et al., 2018). mCherry-DFCP1 colocalized with
GFP-Rab18 and 3 3 Myc-ZW10 on LDs after 6-h OA treatment
(Figure S6D). Knocking down Rab18 and ZW10 causes the for-
mation of supersized LDs in 3T3-L1 preadipocytes (Figures
S6E–S6I) (Xu et al., 2018). However, in Rab18 or ZW10 KD
COS7 cells, the LDs were smaller and more abundant, similar
to DFCP1 KD COS7 cells (Figures S6J–S6Q). DFCP1 KD caused
the formation of supersized LDs in 3T3-L1 cells (Figures S6R and
S6S). These results indicate that Rab18, ZW10, and DFCP1 play
a similar role in LD biogenesis and that inactivation of these
components causes different phenotypes in different cell types.
We used GI-SIM to examine whether Rab18 labels nascent LD
structures. Rab18(Q67L), which exhibits strong LD localization,
was used to facilitate the analysis. GFP-Rab18(Q67L) was
distributed throughout the ER before OA addition (Figure 5A). Af-
ter OA treatment, GFP-Rab18(Q67L) condensed at discrete sites
on the ER that colocalized with mCherry-DFCP1 puncta and ring
structures (Figures 5B and 5C; Video S4). GFP-Rab18(Q67L)-
positive sites and mCherry-DFCP1 puncta emerged from the
ER at the same time, and the two markers moved together
(Figure 5D; Video S4), indicating that Rab18 is also targeted to
nascent LDs. InBSCL2KDCOS7 cells, Rab18 formed numerous
puncta that failed to be stained by LipidTOX (Figures 5E and 5F).
GI-SIM analysis revealed that Rab18 formed punctate structures
that colocalized with nascent DFCP1 puncta in BSCL2 KD cells
after OA treatment (Figures S6T and S6U; Video S5).
We next examined whether Rab18 regulates the LD localiza-
tion of DFCP1 upon LD induction. In Rab18 KD cells, GFP-
DFCP1 failed to enclose LDs after 6-h OA treatment (Figure 5G).
GI-SIM showed that formation of nascent DFCP1 puncta was
also suppressed in Rab18 KD cells after OA treatment (Fig-
ure S7A). Consistent with this, EM analysis revealed that LDs in
Rab18 KD cells were not labeled by APEX2-DFCP1 (Figures
S7B and S7C).Rab18 depletion also suppressed the ER-LD con-
tacts induced by DFCP1 overexpression. The percentage of
LDs, as well as the average perimeter, in contact with the ER in
cells overexpressing GFP-DFCP1 was decreased by simulta-
neous depletion of Rab18 (Figures 5H–5K). ZW10 KD did not
affect the LD localization of DFCP1 (Figure S7D). These results
indicate that Rab18 is required for the LD localization of
DFCP1 and for its function in tethering the ER to LDs.
GFP-Rab18 was still targeted to LDs in DFCP1 KD cells (Fig-
ure S7E), but at a reduced level. The percentage of LDs and
the average perimeter in contact with the ER in cells overex-
pressing Rab18, however, were decreased by DFCP1 KD (Fig-
ures 5L–5P). Therefore, DFCP1 is also required for Rab18-medi-
ated ER-LD contact.
DFCP1 Forms a Complex with Rab18-ZW10
We determined whether DFCP1 is directly recruited to LDs by
Rab18. GFP-DFCP1 precipitated endogenous Rab18 in co-
immunoprecipitation (coIP) assays (Figure 6A). Levels of precip-
itated Rab18 were slightly increased after OA treatment (Fig-
ure 6A). Endogenous DFCP1 was also co-immunoprecipitated
by endogenous Rab18 (Figure 6B). Compared to wild-type
Rab18, the levels of DFCP1 co-precipitated by Rab18(Q67L)
and Rab18(S22N) were more and less, respectively, after 6-h
OA treatment (Figure 6C). In vitro pull-down assays showed
that DFCP1 directly bound to Rab18 and Rab18(Q67L), but not
to GST-Rab18(S22N) (Figures 6D and S7F). The N terminus
and also the ER localization domain of DFCP1 exhibited
Rab18-binding activity in in vitro GST pull-down assays
(H) GFP-DFCP1 is enriched in the LD fraction. Levels of the ER membrane (detected by Sec61b) cofractionated with LDs is increased in GFP-DFCP1 over-
expression cells. PNS, post-nuclear supernatant; TM, total membrane; Cyto, cytosol; LD, lipid droplets. ADRP, LD marker; Sec61b, ER marker.
(I and J) EM images showing ER-LD contacts in NC (I) and DFCP1 KD (J) cells. Arrowheads indicate ER-LD contact sites. Osmium-thiocarbohydrazied-osmium
(OTO) staining was used to enhance the contrast of lipid-containing membranes and droplets. Images showing LDs stained with OTO are indicated. Scale bars,
500 nm.
(K and L) The percentage of LDs displaying contacts with the ER (contacts with a lengthR 0.02 mmwere examined in this study) (K) and the percentage of the LD
perimeter (for LDs contacting the ER) in contact with the ER (L) in NC andDFCP1 KD cells (n = 117 and 132 LDs, respectively). Mean ± SEM is shown. ***p < 0.001;
**p < 0.01.
(M–O) EM images showing ER-LD contacts in cells overexpressingGFP (M), ER(DFCP1)-GFP (N), and GFP-DFCP1 (O). Arrowheads indicate the extensive ER-LD
contact sites. Scale bars, 500 nm.
(P and Q) The percentage of LDs in contact with the ER (P) and the percentage of the LD perimeter in contact with the ER (Q) in NC cells expressing GFP,
ER(DFCP1)-GFP, and GFP-DFCP1 (n = 92, 103 and 103 LDs, respectively). Mean ± SEM is shown. ***p < 0.001.
(R and S) AGFP-Trap assay shows that the level of 33 FLAG-FATP1 co-immunoprecipitated byDGAT2-GFP is higher in DFCP1-overexpressing cells but lower in
DFCP1 KD cells (R). Quantifications of 3 3 FLAG-FATP1 (normalized by DGAT2-GFP) precipitated by DGAT2 are shown in (S) as mean ± SEM (n = 3 individual
experiments). *p < 0.05; ***p < 0.001.
See also Figure S5.
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(Figure S7G). These results suggest that DFCP1 acts as a Rab18
effector.
Endogenous ZW10 was also co-immunoprecipitated by GFP-
DFCP1, and levels of precipitated ZW10were increased after OA
treatment (Figure 6A). The interaction between Rab18 and ZW10
was reduced in DFCP1 KD cells (Figure 6E). Knocking down
Rab18 and ZW10 had no obvious effect on the DFCP1-ZW10
interaction and the DFCP1-Rab18 interaction, respectively (Fig-
ures 6F and S7H). Depletion of one component of the Rab18-
DFCP1-ZW10 complex reduced the levels of the other proteins
(Figure 6G). The ER-localized transmembrane protein EPG-3
(VMP1) modulates the stability of ER-LD contacts (Zhao et al.,
2017). In VMP1 KO cells, the ER-LD contacts are dramatically
increased (Zhao et al., 2017). We found that compared to control
cells, interactions of DFCP1 with Rab18 and ZW10 were
increased in VMP1KO cells (Figure 6H). Therefore, DFCP1 forms
a complex with Rab18-ZW10 and modulates the assembly and/
or stability of the complex.
BSCL2 Modulates ER-LD Contact Mediated by the
DFCP1-Rab18-ZW10 Complex
BSCL2 has been shown to modulate the formation, stabilization,
and function of ER-LD contacts (Salo et al., 2016). We deter-
mined whether BSCL2 regulates ER-LD contacts mediated by
the Rab18-DFCP1 complex. Simultaneous depletion of BSCL2
resulted in the formation of both small and supersized LDs in
Figure 5. Rab18 Is Required for LD Targeting of DFCP1 and for the Role of DFCP1 in Mediating the ER-LD Contact
(A–C) GI-SIM shows that GFP-Rab18(Q67L) colocalizes with mCherry-DFCP1 on the ER before OA addition (A). GFP-Rab18(Q67L) forms discrete sites on the ER
that colocalize with mCherry-DFCP1 puncta and ring structures after OA treatment for 15 min (B) and 20 min (C). Scale bars, 2 mm; inserts, 400 nm.
(D) GI-SIM images at a series of time points after OA treatment shows that mCherry-DFCP1 puncta and GFP-Rab18(Q67L)-positive sites (arrowheads) emerge
from the ER at the same time and move together. Scale bar, 400 nm.
(E and F) After 6-h OA treatment, Rab18 encloses LDs in NC cells (E). In BSCL2 KD cells, Rab18 fails to localize to LipidTOX-positive LDs and form numerous
punctate structures (F).
(G) After 6-h OA treatment, GFP-DFCP1 fails to move to LDs in Rab18 KD cells.
(E–G) Scale bars, 5 mm (inserts, 2 mm).
(H and I) ER-LD contacts (arrowheads) are greatly enhanced in DFCP1-overexpressing cells (H) and reduced by simultaneous depletion of Rab18 (I). LDs are not
stained with OTO in these experiments. Scale bars, 500 nm.
(J and K) Quantification of the percentage of LDs in contact with the ER (J) and the percentage of the LD perimeter in contact with the ER (K) (GFP-DFCP1, n = 106
LDs; Rab18 KD GFP-DFCP1, n = 102 LDs). Mean ± SEM is shown. ***p < 0.001.
(L–N) EM analysis of the ER-LD contact in NC cells (L), Rab18-overexpressing cells (M), and Rab18-overexpressing cells with simultaneousDFCP1 depletion (N).
Scale bars, 500 nm.
(O and P) The percentage of LDs in contact with the ER (O) and the percentage of the LD perimeter in contact with the ER (P) (GFP, n = 106 LDs; GFP-Rab18,
n = 102 LDs; DFCP1 KD GFP-Rab18, n = 109 LDs). Mean ± SEM is shown. ***p < 0.001.
See also Figures S6 and S7.
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Figure 6. DFCP1 Interacts with the Rab18-ZW10 Tethering Complex
(A) A GFP-Trap assay shows that GFP-DFCP1 precipitates endogenous Rab18 and ZW10. Levels of Rab18 and ZW10 (normalized by GFP-DFCP1 levels) are
quantified.
(B) A coIP assay shows that endogenous Rab18 precipitates endogenous DFCP1, ZW10 and BSCL2. Asterisk (*) indicates the band corresponding to BSCL2.
(C) A GFP-Trap assay shows that DFCP1 is co-immunoprecipitated by Rab18(Q67L), but not by Rab18(S22N), after 6-h OA treatment. Wild-type Rab18 also
weakly precipitates DFCP1 in the same assay.
(D) An in vitro pull-down assay shows that DFCP1 directly binds to Rab18. Asterisk (*) indicates the target band.
(legend continued on next page)
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DFCP1- or Rab18-depleted or overexpressing cells (Figures S7I
and S7J; data not shown). Consistent with previous studies (Salo
et al., 2016), association of the ER with the LD surface was
increased on average in BSCL2 KD cells compared to control
cells (Figures 7A, 7B, 7E, and 7F). Enhanced ER-LD contact in
DFCP1-overexpressing cells was suppressed by simultaneous
depletion of BSCL2, so that the extent of ER-LD contact resem-
bled that in BSCL2 single KD cells (Figures 7C–7F).
We examined whether BSCL2 interacts with the DFCP1-
Rab18 complex. In coIP assays, endogenous Rab18 precipi-
tated endogenous BSCL2 (Figure 6B). BSCL2 was also co-
immunoprecipitated by DFCP1 (Figure 6F). The ER domain of
DFCP1 precipitated BSCL2 in coIP assays (Figure S7K). The
interaction between DFCP1 and BSCL2 was not affected by
OA treatment (Figure S7L) but was greatly suppressed in
Rab18 KD cells (Figure 6F), suggesting that Rab18 facilitates
the interaction between BSCL2 and DFCP1. The interaction of
Rab18 with BSCL2 was not reduced in ZW10 KD cells (Fig-
ure S7H). Levels of endogenous Rab18 and ZW10 co-precipi-
tated by DFCP1 were not evidently affected by BSCL2 depletion
(Figure S7M). These results suggested that BSCL2 interacts with
the Rab18-DFCP1-ZW10 complex to modulate ER-LD contact
formation. Depletion of Rab18 or DFCP1 also suppressed the
increased ER-LD contact in BSCL2 KD cells (Figures 7G–7N),
indicating that the DFCP1-Rab18 complex also modulates ER-
LD contact independent of BSCL2.
DISCUSSION
Fusion of DFCP1-Labeled Nascent LD Structures at the
Early Stages of LD Biogenesis
LDs are generated from the ER (Walther et al., 2017; Qi et al.,
2017). Neutral lipids synthesized in the ER membrane bilayer
accumulate into lens-like structures, which further grow and
bud into the cytoplasm. These newly budded nascent LDs do
not contain enough lipids to be detected by neutral lipid dyes
(e.g., BODIPY and LipidTOX) but can be labeled by HPos and
LiveDrop (Kassan et al., 2013; Wang et al., 2016). The nascent
LDs reassociate with the ER to acquire more lipids and/or TG
synthesis enzymes (e.g., GPAT4 and DGAT2) to generate TG
for LD growth (Wang et al., 2016; Salo et al., 2016).
Using super-resolution GI-SIM, which has a much higher
speed and greater imaging depth than confocal microscopy
(Nixon-Abell et al., 2016), we visualized the dynamics of early
steps involved in LD formation. Upon LD induction, small
DFCP1 puncta emerge from the ER, and the formation of these
puncta depends on TG synthesis. DFCP1 puncta appear earlier
and are more abundant than puncta labeled by HPos and Live-
Drop. Formation of DFCP1-labeled nascent structures is revers-
ible, and the majority of them dissipate into the ER. The DFCP1-
labeled puncta move along the ER, fuse with each other, and
mature into more advanced LD structures that are positive for
both HPos and DFCP1. The double-positive puncta are mainly
located at ER three-way junctions and further grow into mature
LDs (Figure 7O). Thus, formation of DFCP1-positive nascent
structures constitutes an early step of LD formation. How
DFCP1 concentrates at discrete sites upon LD induction remains
unresolved, as does the nature of DFCP1 puncta. Nascent
DFCP1 structures may be enriched in TGs. Alternatively,
DFCP1 may accumulate at ER sites with a membrane change
associated with LD formation.
In BSCL2 KD cells, the dissipation of DFCP1 puncta into the
ER and fusion of nascent LDs and their maturation into expand-
ing LDs at three-way junctions is greatly inhibited. The mecha-
nism by which BSCL2 controls the dynamics of DFCP1 puncta
at early stages of LD biogenesis has yet to be determined.
BSCL2 could mediate the reengagement of nascent LDs with
the ER and/or stabilize them on the ER by interacting with the
DFCP1-Rab18 complex and other unidentified factors. Another
possibility is that BSCL2 may modulate the lipid and protein
composition of nascent DFCP1 structures to specify their fusion
capability.
DFCP1 Forms a Complex with Rab18-ZW10 to Mediate
ER-LD Contact
Targeting DFCP1 to nascent and mature LDs requires Rab18.
DFCP1 acts as a Rab18 effector. DFCP1 binds strongly to
active mutant Rab18(Q67L), but not to GDP-bound mutant
Rab18(S22N). Rab18 directly interacts with ZW10, which further
interacts with ER-localized SNAREs to establish ER-LD contact
(Xu et al., 2018). DFCP1 mediates the ER-LD contact by forming
a complex with Rab18 and ZW10. The number of LDs and also
the average length of the LD perimeter in contact with the ER
is increased by overexpression of DFCP1 and reduced by deple-
tion of DFCP1. The enhanced ER-LD contact caused by DFCP1
overexpression depends on Rab18, and the enhanced ER-LD
contact induced by Rab18 overexpression requires DFCP1. In
VMP1/EPG-3-depleted cells, in which ER-LD contact is greatly
enhanced (Zhao et al., 2017), the formation of the DFCP1-
Rab18-ZW10 complex is elevated. LD biogenesis is modulated
by ER-LD contact. The LDs are smaller and more numerous in
DFCP1 KDCOS7 and HeLa cells and larger in cells overexpress-
ing DFCP1. In Rab18 or ZW10 KD COS7 and HeLa cells, LDs
are also smaller and greater in number. Formation of the
FATP1-DGAT2 complex at ER-LD contact sites for TG synthesis
is reduced by DFCP1 depletion and enhanced by DFCP1
(E) The interaction betweenRab18 and ZW10 is reduced inDFCP1KD cells. Levels of ZW10 co-precipitated byGFP-Rab18 (normalized byGFP-Rab18 levels) are
quantified.
(F) Endogenous ZW10 and BSCL2 proteins are co-immunoprecipitated by GFP-DFCP1. Levels of BSCL2 and ZW10 (normalized by GFP-DFCP1 levels) are
quantified. Asterisk (*) indicates the band corresponding to BSCL2.
(G) Knocking downRab18,DFCP1, andZW10 reduces the levels of other proteins. Levels of Rab18, DFCP1, and ZW10 (normalized by Actin levels) are quantified.
Asterisk (*) indicates the band corresponding to DFCP1.
(H) Levels of endogenous Rab18 and ZW10 co-immunoprecipitated by GFP-DFCP1 are enhanced in VMP1 knockout (KO) cells. Levels of Rab18 and ZW10
(normalized by GFP-DFCP1 levels) are quantified.
See also Figure S7.
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Figure 7. BSCL2 Modulates ER-LD Contact Mediated by the Rab18-DFCP1 Complex
(A–D) EM analysis of ER-LD contact in NC cells (A), BSCL2 KD cells (B), DFCP1-overexpressing cells (C), and DFCP1-overexpressing cells with simultaneous
BSCL2 depletion (D). The ER-LD contact site is indicated by arrowheads. Scale bars, 500 nm.
(legend continued on next page)
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overexpression (Xu et al., 2012). The DFCP1-Rab18-ZW10 com-
plex may also interact with lipid transfer proteins or regulate
other aspects of LDs such as lipid and protein composition to
modulate LD biogenesis.
Two types of ER-LD contact have been reported that act
differently in lipid and protein transfer. One type involves close
apposition of the ER to LDs. Formation of these contacts ismedi-
ated by protein-protein and/or protein-phosphoinositide interac-
tions (Phillips and Voeltz, 2016). Another type of contact contains
membrane extensions linking the ER to LDs. Neutral lipids gener-
ated in the ER and ER-localized TG synthesis enzymes are
directly transferred via these extensions to LDs. LDs in different
cell types have unique features such as lipid composition and LD
proteins. For example, phospholipid metabolismmay be distinct
and the LD fusion-promoting protein Fsp27 may be differentially
expressed in different cell types (Gong et al., 2011; Qi et al.,
2017). Formation of these two types of ER-LD contact may be
differentially modulated by the DFCP1-Rab18-ZW10 complex
in different cell types. In 3T3-L1 cells, depletion of components
of the DFCP1-Rab18-ZW10 complex leads to formation of su-
persized LDs, which could be caused by the formation of mem-
brane extensions between the ER and LDs (Wolinski et al., 2015).
BSCL2 Regulates the Role of the DFCP1-Rab18-ZW10
Complex in ER-LD Contact Formation
BSCL2 forms distinct puncta at ER-LD contact sites and modu-
lates the formation, stabilization, and function of ER-LD contacts
(Wang et al., 2016; Salo et al., 2016; Cartwright et al., 2015).
BSCL2 has been shown to facilitate the transport of proteins
such as ACSL3 and HPos from the ER into expanding LDs
and/or to prevent equilibration of ER and LD surface compo-
nents (Wang et al., 2016; Salo et al., 2016). We found that in
the absence of BSCL2, trafficking of DFCP1 and Rab18 to
nascent LD structures occurs, while their localization to mature
LDs is greatly reduced, which may result from their impaired
transfer from the ER to expanding LDs or retention at the LD
monolayer. Depletion of BSCL2 suppresses the enhanced ER-
LD contact in DFCP1- or Rab18-overexpressing cells. BSCL2
may directly participate in contact formation by interacting with
the DFCP1-Rab18 complex. It is also possible that BSCL2 mod-
ulates the lipid and protein composition at the contact sites,
which in turn facilitates the ER-LD contact mediated by the
DFCP1-Rab18 complex. In BSCL2 KO cells, ER-LD contacts
are heterogeneous and irregular. A fraction of LDs, including su-
persized LDs, exhibit extensive contact and membrane bridges
with the ER (Salo et al., 2016). The enhanced ER-LD contact in
BSCL2 KD cells is suppressed by simultaneous depletion of
Rab18 or DFCP1. Thus, the DFCP1-Rab18 complex has a
BSCL2-independent function in tethering the ER with LDs.
The LD defect in DFCP1- and Rab18-depleted COS7 and
HeLa cells is not identical to that in BSCL2 KD cells. DFCP1
KD and Rab18 KD cells contain uniformly small LDs that are
stained by lipid dyes. The LDs in BSCL2 KD cells are heteroge-
neous in size and include the supersized LDs that may result
from premature targeting of lipid synthesis enzymes and/or LD
coalescence due to changes in phospholipid composition
(Wang et al., 2016; Salo et al., 2016; Wolinski et al., 2015).
BSCL2 appears to have other functions in the control of LD
biogenesis in addition to mediating ER-LD membrane contact.
Our study shows that the DFCP1-Rab18 complex is involved in
modulating the formation and/or stability of ER-LD contacts to
regulate LD biogenesis.
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(E and F) The percentage of LDs in contact with the ER (E) and the percentage of the LD perimeter in contact with the ER (F) (NC, n = 92 LDs; BSCL2 KD, n = 158
LDs; GFP-DFCP1, n = 103 LDs; BSCL2 KD GFP-DFCP1, n = 139 LDs). Mean ± SEM is shown. ***p < 0.001; **p < 0.01; *p < 0.05; ns, not significant. Data for cells
expressing GFP and GFP-DFCP1 are from Figures 4P and 4Q. These experiments were performed at the same time.
(G–L) EM analysis of ER-LD contact in NC cells (G), BSCL2 KD cells (H), DFCP1 KD cells (I), Rab18 KD cells (J), and DFCP1 KD cells with simultaneous BSCL2
depletion (K) and Rab18 KD cells with simultaneous BSCL2 depletion (L). Arrowheads indicate ER-LD contact sites. Scale bars, 500 nm.
(M and N) Quantification of the percentage of LDs in contact with the ER (M) and the percentage of the LD perimeter in contact with the ER (N) (NC, n = 103 LDs;
BSCL2KD, n = 155 LDs;DFCP1KD, n = 102 LDs;Rab18KD, n = 114 LDs;DFCP1KDwith simultaneous KDBSCL2, n = 129 LDs;Rab18KDwith simultaneous KD
BSCL2, n = 132 LDs). Mean ± SEM is shown. ***p < 0.001; **p < 0.01; *p < 0.05
(O and P) Models for the initial stage of LD formation in control and BSCL2-deficient cells. Upon LD induction, DFCP1 associates with nascent LD structures in a
manner that depends on TG synthesis. These nascent LDs move along the ER and fuse with each other at the ER three-way junction site to form expanding LDs.
The nascent LDs may have detached from the ER or remain connected with the ER via thin membrane bridges. The nascent LDs can also dissipate into the ER.
HPos mainly labels the expanding LD at ER three-way junction sites. BSCL2 modulates the dynamics and maturation of nascent LDs (stage one). As the ex-
panding LDs grow in size, DFCP1 and Rab18 are also transported from the ER to the LD (stage two). The insert in (O) shows the formation of the DFCP1-Rab18-
ZW10 complex at the ER-LD contact site. InBSCL2-deficient cells, dissipation of nascent DFCP1 puncta into the ER is inhibited. A few LDs engagewith the ER for
growth (P).
See also Figure S7.
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B Immunoelectron microscopy
B FRAP experiment
B Grazing incidence SIM
d QUANTIFICATION AND STATISTICAL ANALYSIS
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.
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Rabbit polyclonal anti-ADRP Proteintech Cat#15294-1-AP
Mouse polyclonal anti-BSCL2 Abnova Corporation Cat#H00026580-A02; RRID:AB_627320
Rabbit polyclonal anti-Rab18 Sigma-Aldrich Cat#SAB4200173; RRID:AB_10638775
Rabbit polyclonal anti-ZW10 Proteintech Cat#24561–1-AP
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siRNA Human DFCP1: 50-GAUCGAAUGUCCUAACUGUTT 30 This paper N/A
siRNA Mouse DFCP1: 50-GCCUGGAACUGAUGCAUUUTT-30 This paper N/A
siRNA Monkey BSCL2: 50-GGUGUCUGUCUUCCUCUAUTT-30 This paper N/A
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Hong
Zhang (hongzhang@ibp.ac.cn).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell culture
HeLa, COS7 and 3T3-L1 preadipocyte (from ATCC) cells were cultured in medium containing DMEM (SH30022.01B, Hyclone)
and 10% FBS (SH30084.03, Hyclone) with penicillin-streptomycin at 37C and 5% CO2. None of these cell lines listed above as
misidentified or cross-contaminated in the International Cell Line Authentication Committee (ICLAC) database, and all were free
of mycoplasma contamination.
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BSCL2-3xMyc This paper N/A
mCherry-HPos This paper N/A
ER(DFCP1)+FYVE(FENS)-GFP This paper N/A
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Cells were treated with 5 mM wortmannin (PHZ1301, Life Technologies) for 4 hr to inhibit PI(3)P kinase. Cells were incubated with
0.2 mMOA (oleic acid, O7501, Sigma) for the indicated time to induce LD formation. Cells were incubated with 5 mMDGAT1 inhibitor
D1i (A922500, TOCRIS) for 6 hr in the presence of OA to inhibit TG synthesis.
METHOD DETAILS
Plasmids
Human DFCP1 cDNA was cloned into pFlag-CMV4 vector, pEGFP-C3 vector, pmCherry-C1 and pTagRFP-N1 vector.
DER+FYVE(DFCP1)-GFP, ER(DFCP1)-GFP, FYVE(DFCP1)-GFP and ER+FYVE(DFCP1)-GFP were generated by cloning DFCP1 (aa
1-415), DFCP1 (aa 416-543), DFCP1 (aa 585-777), and DFCP1 (aa 416-777) into pEGFP-N1 vector, respectively. GFP-DFCP1(W543A)
and GFP-DFCP1(C650S, C770S) were generated by PCR-based mutagenesis from GFP-DFCP1. Human Rab18 was cloned into
pEGFP-C1 vector. GFP-Rab18(Q67L) and GFP-Rab18(S22N) were generated by PCR-based mutagenesis from GFP-Rab18. Human
cDNA encoding BSCL2 was inserted into pEGFP-N1 vector. BSCL2-3xMyc was generated by adding 3xMyc to the C terminus of
BSCL2. mCherry-HPos was constructed by cloning HPos into pmCherry-C1 vector. ER(DFCP1)+FYVE(FENS)-GFP was generated
by inserting human FENS (aa 276-358) into ER(DFCP1)-GFP. GFP-HPoswas kindly provided byDr. Albert Pol (Institut d’Investigacions
Biome`diques August Pi i Sunyer). FYVE(FENS)-TM(CYTOB5)-GFP was kindly provided by Dr. Nicholas T. Ktistakis (Babraham
Institute). GFP-LiveDrop, GFP-Sec61b and RFP-Sec61b were kindly provided by Dr. Junjie Hu (Institute of Biophysics, Chinese
Academy of Sciences).
Transfection and RNA interference
Transfection of plasmids was carried out with Lipofectamine 2000 (12566014, Life Technologies). Cells were transfected with NC or
siRNA oligos, which were purchased from GenePharma using Lipofectamine RNAiMAX (13778150, Life Technologies), and cultured
for 72 hr before analysis. RNAi sequences were listed in KEY RESOURCES TABLE.
Lipid droplet staining assay
Cells were washed with PBS three times and fixed with 4% PFA for 20 min. After washing with PBS, LDs were stained with LipidTOX
(1:1000, H34476, Life Technologies) for 15 min at room temperature. Coverslips were mounted with DAPI in 50% glycerol and
examined under a confocal microscope (LSM 880 Meta plus Zeiss Axiovert zoom, Zeiss) with a 63 3 oil-immersion objective lens
(Plan-Apochromatlan, Zeiss) and a camera (Axiocam HRm, Zeiss).
Membrane fractions
After washing with PBS 3 times, cells were scraped into 1 mL ice cold buffer E (20 mMHEPES, pH 7.4, 250 mM sucrose, 1 mM EDTA
and protease inhibitor cocktail), 1 mL pH 11.5 buffer (100 mM sodium carbonate, pH 11.5) or 1 mL high salt buffer (10 mM Tris-HCl,
pH 8.0/ 0.5 M NaCl). Cells were then homogenized with 100 strokes in a Dounce homogenizer (K885300-0002, Thermo Fisher). After
being centrifuged at 20,000 g, the homogenates (total sample) were incubated for 30 min at 4C and then ultracentrifuged at
200,000 g for 1 hr at 4C. The supernatants were transferred to a new tube and the pellet was resuspended in the same volume
of the original buffer. Total sample, supernatant and pellet fractions were resuspended in SDS-sample buffer and analyzed by
immunoblotting.
LD mobility
Cells were seeded into glass-bottom dishes (801001, NEST) and transfected with NC or siRNA oligos for 48 hr and the indicated plas-
mids for the last 24 hr. After LipidTOX staining (1:1000, H34475, Life Technologies) for 15min, cells were imaged at 37C and 5%CO2
using a 1003 objective (CFI Plan Apochromat Lambda, NA 1.45, Nikon) with immersion oil on an inverted fluorescence microscope
(Eclipse Ti-E, Nikon) with a spinning-disk confocal scanner unit (UltraView, PerkinElmer). Image sequences were captured every 1 s
for 200 s. The images were cropped to find discrete items and track objects, and the mean velocity of objects of interest was
analyzed with Velocity software (PerkinElmer).
LD purification
Cells were washed with ice-cold PBS, and then harvested by centrifugation at 3,000 g for 10 min (Sigma 12150-H). Cells were then
washed twice with 30 mL buffer A (25 mM tricine, 250 mM sucrose, pH 7.8), and resuspended in 30 mL buffer A. Cells were homog-
enized by passing through a French pressure cell at 100MPa, 4C. The sample was centrifuged at 3,000 g for 10min. The supernatant
fraction was transferred to a SW40 tube. 2 mL buffer B (20 mM HEPES, 100 mM KCl, 2 mMMgCl2, pH 7.4) was added on top of the
supernatant and then centrifuged at 182,000 g for 1 h at 4C (Beckman SW40). The LD fraction was transferred to a 1.5mL Eppendorf
tube, washed with buffer B three times and then dissolved with chloroform-acetone (1:1) to precipitate proteins. After centrifugation
at 20,000 g for 10 min, the pellet was dissolved with 2 3 SDS sample buffer and denatured at 95C for 5 min for further analysis.
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Co-immunoprecipitation assays
After transfection with the indicated plasmids for 24 hr, COS7 cells were washed 3 times and dispersed in lysis buffer (50mMHEPES,
pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100 and protease inhibitor cocktail) for 30 min. After the lysates were centrifuged at
20,000 g for 10min at 4C, the supernatants were transferred to a new tube. 50 ml of each supernatant were saved as input. For GFP-
Trap assays, the rest of the supernatant was immunoprecipitated by GFP-Trap agarose beads (gta-20, ChromoTek) for 1.5 hr at 4C.
After washing, the samples were resuspended in SDS-sample buffer and analyzed by immunoblotting. For IP of endogenous protein,
antibody was premixed with the rest of the supernatant for 2 hr at 4C, and then incubated with protein G beads (Roche) for 1 hr at
4C. After washing, the samples were resuspended in SDS-sample buffer and analyzed by immunoblotting.
Protein expression and purification
GST-Rab18 and GST-DFCP1 were generated by inserting PCR-amplified human genes into pGEX-6P-1 vector to produce GST-tag
proteins. GST-Rab18(Q67L) and GST-Rab18(S22N) were generated by PCR-based mutagenesis from GST-Rab18. GST-DFCP1(aa
1-412), GST-DFCP1(aa 412-544) and GST-DFCP1(aa 544-777) were generated by truncating GST-DFCP1. A modified version of
pET-32a (Novagen) with Trx-His6-tag at the N terminus was used to generate His-Rab18. Human DFCP1 was cloned into pET-
28a to generate His-DFCP1. Recombinant proteins were expressed in Escherichia coli BL21-CodenPlus (DE3) and purified using
Sepharose 4B beads (GST-tagged protein, GE Healthcare). After loading onto desalting columns (GE Healthcare), proteins were
finally eluted with 1 3 PBS buffer. GST-Rab18(Q67L) and GST-Rab18(S22N) used buffer containing 50 mM Tris-HCl (pH 8.0),
500 mM NaCl and 2 mM DTT.
In vitro pulldown assays
GST or GST-tagged protein (20 mg) and His-tagged protein (50 mg) were incubated with 20 mL GST beads in 500 mL pulldown buffer
(1 3 PBS, 0.1% Triton X-100) for 1 hr at 4C. After washing 3-5 times with pulldown buffer, proteins were resuspended in 5 3 SDS-
sample buffer and visualized by immunoblotting. GST-DFCP1 protein was incubatedwith protease inhibitor cocktail (Roche, B14003)
for 1 hr at 4C. For GST-tagged mutants of Rab18, the pulldown buffer (20 mM HEPES (pH 7.4), 200 mM NaCl, 0.1% Triton X-100)
was supplemented with 5mMGTP for GST-Rab18(Q67L) or 5mMGDP for GST-Rab18(S22N) and 5mMMg2+. To examine the inter-
action between His-Rab18 and GST-tagged DFCP1 fragments, 5 mM GTP and 5 mM Mg2+ were included in the pulldown buffer.
Electron microscopy
Cells (1x106) were transfected with NC and/or indicated siRNA oligos for 72 hr. For cells transfected with plasmids expressing GFP-
tagged proteins, GFP-positive cells were sorted by flow cytometry (BD FACSAria IIIu). Collected cells were fixed with 2.5% glutar-
aldehyde in PBS overnight at 4C. After 3 washes in the same buffer, cells were post-fixed in 1% OsO4 and 0.05% potassium
ferrocyanide for 45 min. Cells were then washed with water and dispersed in thiocarbohydrazide (TCH) solution for 30 min at
room temperature. Then cells were washed again and incubated with 1%OsO4 for 45 min at room temperature. After washing, cells
were further dehydrated by a graded series of ethanol solutions and embedded in epoxy resin.
For OTO (ferrocyanide reduced osmium tetroxide post-fixation, thiocarbohydrazide-osmium liganding) staining, samples were
subjected to graded dehydration and embedding, then ultrathin sections were stained with uranyl acetate and lead citrate.
For DAB staining, cells were transfected with a construct expressing an APEX2 fusion protein. Cells were sorted by flow cytometry
and then fixed with 2.5% glutaraldehyde in PBS overnight at 4C and rinsed 3 3 10 min in PBS. Cells were treated with a freshly
diluted solution of 0.5 mg/ml (1.4 mM) DAB tetrahydrochloride for 12 min, then rinsed 3 3 10 min with chilled buffer. Cells were
post-fixed in 1% OsO4 for 90 min at room temperature. Cells were rinsed 3 3 10 min in chilled distilled water, and then placed in
chilled 2% aqueous uranyl acetate (Electron Microscopy Sciences) for 1 hour. A 120 kV electron microscope (H-7650B, Hitachi)
was used at 80 kV. Images were captured with an AMTCCD camera (XR-41) using Digital Micrograph software at room temperature.
3D-structured illumination microscopy
3D-structured illumination microscopy (3D-SIM) images of COS7 cells were acquired on a DeltaVision OMX V3 imaging system (GE
Healthcare) with a 3 100/1.40 NA oil objective (Olympus UPlanSApo), solid-state multimode lasers (488, 405 nm, 561nm) and elec-
tron-multiplying CCD (charge-coupled device) cameras (Evolve 512 3 512, Photometrics). Serial Z stack sectioning was done at
125 nm intervals for SIM mode. To obtain optimal images, immersion oils with refractive indices of 1.512 were used for COS7 cells
on glass coverslips. The microscope was routinely calibrated with 100 nm fluorescent spheres to calculate both the lateral and axial
limits of image resolution. SIM image stacks were reconstructed using softWoRx 6.1.1 (GE Healthcare) with the following settings:
pixel size 39.5 nm; channel-specific optical transfer functions; wiener filter constant 0.0010; discard negative intensities background;
drift correction with respect to first angle; custom K0 guess angles for camera positions. The 3D reconstruction of the GFP-DFCP1-
and LipidTOX-stained LD surface was processed using Imaris x64 8.1.4 software.
Immunoelectron microscopy
Cells were fixed in buffer containing 2% paraformaldehyde, 0.2% glutaraldehyde and Na cacodylate (pH 7.4) for 2 hr at 37C. After
dehydration and embedding in acrylic resin (LR White), 70 nm ultrathin sections were mounted on nickel grids, and then the nickel
grids were incubated in 1%BSA diluted with PBS containing the indicated antibodies at 4C overnight. After washing with 0.2%BSA
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diluted with PBS, the nickel grids were probed with gold-conjugated particles in 1% BSA diluted with PBS for 2 hr at room temper-
ature. The ultrathin sections were then stained and examined. Images were captured by a Gatan-832 digital camera on a 120 kV Jeol
electron microscope (JEM-1400) at 80 kV.
FRAP experiment
LDswere stainedwith LipidTOX for 15min and then fluorescence recovery after photobleaching (FRAP) experiments were performed
on a confocal microscope (LSM 880 Meta plus Zeiss Axiovert zoom, Zeiss) using a 633 oil immersion objective lens (Plan-Apochro-
matlan, Zeiss) and a camera (Axiocam HRm, Zeiss) at room temperature. A defined region of interest was photobleached at full laser
power at 488 nm (100%power, 20 iterations). Fluorescence intensity was normalized to the pre-bleach intensity. Image intensity was
measured by Mean ROI on a confocal microscope (LSM 880 Meta plus Zeiss Axiovert zoom, Zeiss) and further analyzed by Prism
(GraphPad).
Grazing incidence SIM
After seeding on 25-mmcoverslips, COS7 cells were transfected with NC or siRNA oligos for 48 hr, and transfected with the indicated
plasmids for the last 24 hr. Before imaging, COS7 cells were stained with LipidTOX for 15 min.
The grazing incidence structured illumination microscopy (GI-SIM) apparatus was built based on an inverted fluorescence micro-
scope (IX83, Olympus, Japan). In this system, the light beams from a laser combiner equipped with 488 nm (500 mW, Coherent,
Genesis Max 488-500 STM), and 560 nm (1W, MPB Communications, VFL-P-500-560) lasers are passed through an acousto-optic
tunable filter (AOTF; AA Quanta Tech, AOTFnc-400.650-CPch-TN), which is used to dynamically select the excitation laser and con-
trol its power inputting into the backward light path. The output beam from the AOTF is then expanded to a 1/e diameter of 12mmand
sent to a phase-only modulator consisting of a polarizing beam splitter, an achromatic half-wave plate (HWP; Bolder Vision Optik,
BVO AHWP3), and a ferroelectric spatial light modulator (SLM; Forth Dimension Displays, SXGA-3DM). The light diffracted by the
grating pattern displayed on the SLM passes through a polarization rotator consisting of a liquid crystal cell (LC; Meadowlark, SWIFT)
and an achromatic quarter wave plate (QWP; Bolder Vision Optik, BVOAQWP3), which rotates the linear polarization of the diffracted
light so as to maintain the S-polarization necessary to maximize the pattern contrast for all pattern orientations.
Images were captured with an Olympus 1.7-NA objective under the physiological conditions of 37C and 5% CO2. Three raw
images were acquired at successive phase steps of 0, 1/3, and 2/3 for each illumination time-point. This process was repeated
with the standing wave excitation pattern rotated ± 120 with respect to the first orientation, for a total of nine raw images.
In this work, we used an imaging speed of 1 frame per 4, 5 or 10 s at 50 W/cm2 excitation intensity, and continuously imaged
200 time-points.
QUANTIFICATION AND STATISTICAL ANALYSIS
Immunoblotting, in-vitro pulldown andCo-IP results are representative of three independent experiments. Dead/unhealthy cells were
excluded from analysis. The cells or images for analysis were randomly chosen. No specific randomization method was applied. The
statistical parameters, including n, SEM and SD, are reported in the Figures and corresponding Figure Legends. Statistical analysis
was performed in Microsoft Excel, Prism (GraphPad) and ImageJ. Statistical significance was calculated by one-way ANOVA anal-
ysis. AP value < 0.05was considered significant. For comparison of the percentage of LDs in contact with the ER, the Chi-square test
was used to test significance. No statistical methods were used to predetermine the sample size, or to determine whether the data
met the assumptions of the statistical approaches used.
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